Patient Name : Mr.
CHINMOY DEBNATH Collected : 26/May/2025 09:20AM
Age/Gender : 23 Y 0 M 0 D /M Received : 26/May/2025 02:00PM
UHID/MR No : DAGR.0000182238 Reported : 26/May/2025 04:45PM
Visit ID : DAGROPV194471 Status : Final Report
Ref Doctor : [Link] Client Name : PUP 24X7 HEALTHCARE
IP/OP NO : Center location : DHALESWAR,AGARTALA
DEPARTMENT OF HAEMATOLOGY
Test Name Result Unit Bio. Ref. Interval Method
COMPLETE BLOOD COUNT (CBC) , WHOLE BLOOD EDTA
HAEMOGLOBIN 15.3 g/dL 13-17 Spectrophotometer
PCV 43.80 % 40-50 Electronic pulse &
Calculation
RBC COUNT 5.42 Million/[Link] 4.5-5.5 Electrical Impedence
MCV 83.6 fL 83-101 Calculated
MCH 28.3 pg 27-32 Calculated
MCHC 33.4 g/dL 31.5-34.5 Calculated
R.D.W 14.0 % 11.6-14 Calculated
TOTAL LEUCOCYTE COUNT (TLC) 8,300 cells/[Link] 4000-10000 Electrical Impedance
DIFFERENTIAL LEUCOCYTIC COUNT (DLC)
NEUTROPHILS 58 % 40-80 Electrical Impedance
LYMPHOCYTES 37 % 20-40 Electrical Impedance
EOSINOPHILS 02 % 1-6 Electrical Impedance
MONOCYTES 03 % 2-10 Electrical Impedance
BASOPHILS 00 % 0-2 Electrical Impedance
CORRECTED TLC 8,300 Cells/[Link] Calculated
ABSOLUTE LEUCOCYTE COUNT
NEUTROPHILS 4814 Cells/[Link] 2000-7000 Calculated
LYMPHOCYTES 3071 Cells/[Link] 1000-3000 Calculated
EOSINOPHILS 166 Cells/[Link] 20-500 Calculated
MONOCYTES 249 Cells/[Link] 200-1000 Calculated
Neutrophil lymphocyte ratio (NLR) 1.57 0.78- 3.53 Calculated
PLATELET COUNT 231000 cells/[Link] 150000-410000 Electrical impedence
Page 1 of 6
SIN No:HA09013788
Patient Name : [Link] DEBNATH Collected : 26/May/2025 09:20AM
Age/Gender : 23 Y 0 M 0 D /M Received : 26/May/2025 09:39AM
UHID/MR No : DAGR.0000182238 Reported : 26/May/2025 10:57AM
Visit ID : DAGROPV194471 Status : Final Report
Ref Doctor : [Link] Client Name : PUP 24X7 HEALTHCARE
IP/OP NO : Center location : DHALESWAR,AGARTALA
DEPARTMENT OF BIOCHEMISTRY
Test Name Result Unit Bio. Ref. Interval Method
GLUCOSE, FASTING , NAF PLASMA 97 mg/dL 70-100 GOD - POD
Comment:
As per American Diabetes Guidelines, 2023
Fasting Glucose Values in mg/dL Interpretation
70-100 mg/dL Normal
100-125 mg/dL Prediabetes
≥126 mg/dL Diabetes
<70 mg/dL Hypoglycemia
Note:
[Link] diagnosis of Diabetes requires a fasting plasma glucose of > or = 126 mg/dL and/or a random / 2 hr post glucose value of
> or = 200 mg/dL on at least 2 occasions.
2. Very high glucose levels (>450 mg/dL in adults) may result in Diabetic Ketoacidosis & is considered critical.
Page 2 of 6
SIN No:BI25966392
Patient Name : [Link] DEBNATH Collected : 26/May/2025 09:20AM
Age/Gender : 23 Y 0 M 0 D /M Received : 26/May/2025 09:39AM
UHID/MR No : DAGR.0000182238 Reported : 26/May/2025 11:40AM
Visit ID : DAGROPV194471 Status : Final Report
Ref Doctor : [Link] Client Name : PUP 24X7 HEALTHCARE
IP/OP NO : Center location : DHALESWAR,AGARTALA
DEPARTMENT OF BIOCHEMISTRY
Test Name Result Unit Bio. Ref. Interval Method
LIPID PROFILE , SERUM
TOTAL CHOLESTEROL 230 mg/dL <200 CHE/CHO/POD
TRIGLYCERIDES 257 mg/dL <150 Enzymatic
HDL CHOLESTEROL 33 mg/dL >40 CHE/CHO/POD
NON-HDL CHOLESTEROL 197 mg/dL <130 Calculated
LDL CHOLESTEROL 145.2 mg/dL <100 Calculated
VLDL CHOLESTEROL 51.4 mg/dL <30 Calculated
CHOL / HDL RATIO 6.89 0-4.97 Calculated
ATHEROGENIC INDEX (AIP) 0.53 <0.11 Calculated
Comment:
Reference Interval as per National Cholesterol Education Program (NCEP) Adult Treatment Panel III Report.
Desirable Borderline High High Very High
TOTAL CHOLESTEROL < 200 200 - 239 ≥ 240
TRIGLYCERIDES <150 150 - 199 200 - 499 ≥ 500
Optimal < 100
LDL 130 - 159 160 - 189 ≥ 190
Near Optimal 100-129
HDL ≥ 60
Optimal <130;
NON-HDL CHOLESTEROL 160-189 190-219 >220
Above Optimal 130-159
Page 3 of 6
SIN No:BI25966393
Patient Name : [Link] DEBNATH Collected : 26/May/2025 09:20AM
Age/Gender : 23 Y 0 M 0 D /M Received : 26/May/2025 09:39AM
UHID/MR No : DAGR.0000182238 Reported : 26/May/2025 11:40AM
Visit ID : DAGROPV194471 Status : Final Report
Ref Doctor : [Link] Client Name : PUP 24X7 HEALTHCARE
IP/OP NO : Center location : DHALESWAR,AGARTALA
DEPARTMENT OF BIOCHEMISTRY
Test Name Result Unit Bio. Ref. Interval Method
LIVER FUNCTION TEST (LFT) , SERUM
BILIRUBIN, TOTAL 1.00 mg/dL 0-1.2 DIAZO METHOD
BILIRUBIN CONJUGATED (DIRECT) 0.20 mg/dL 0.0-0.3 Calculated
BILIRUBIN (INDIRECT) 0.80 mg/dL 0.0-1.1 Calculated
ALANINE AMINOTRANSFERASE 117 U/L <50 Visible with P-5-P
(ALT/SGPT)
ASPARTATE AMINOTRANSFERASE 50.0 U/L 17-59 UV with P-5-P
(AST/SGOT)
AST (SGOT) / ALT (SGPT) RATIO (DE 0.4 <1.15 Calculated
RITIS)
ALKALINE PHOSPHATASE 63.00 U/L 38-126 p-nitrophenyl
phosphate
PROTEIN, TOTAL 8.10 g/dL 6.3-8.2 Biuret
ALBUMIN 4.90 g/dL 3.5 - 5 Bromocresol Green
GLOBULIN 3.20 g/dL 2.0-3.5 Calculated
A/G RATIO 1.53 0.9-2.0 Calculated
Comment:
LFT results reflect different aspects of the health of the liver, i.e., hepatocyte integrity (AST & ALT), synthesis and secretion of
bile (Bilirubin, ALP), cholestasis (ALP, GGT), protein synthesis (Albumin) Common patterns seen:
1. Hepatocellular Injury: *AST – Elevated levels can be seen. However, it is not specific to liver and can be raised in cardiac and
skeletal injuries.*ALT – Elevated levels indicate hepatocellular damage. It is considered to be most specific lab test for
hepatocellular injury. Values also correlate well with increasing BMI. Disproportionate increase in AST, ALT compared with
ALP. AST: ALT (ratio) – In case of hepatocellular injury AST: ALT > 1In Alcoholic Liver Disease AST: ALT usually >2. This
ratio is also seen to be increased in NAFLD, Wilsons’s diseases, Cirrhosis, but the increase is usually not >[Link]- If both SGPT
and SGOT are within reference range then AST:ALT (De Ritis ratio) does not have any clinical significance.
2. Cholestatic Pattern:*ALP – Disproportionate increase in ALP compared with AST, ALT. ALP elevation also seen in
pregnancy, impacted by age and sex.*Bilirubin (Direct) and GGT elevated- helps to establish hepatic origin.
3. Synthetic function impairment:*Albumin- Liver disease reduces albumin levels, Correlation with PT (Prothrombin Time) helps.
4. Associated tests for assessment of liver fibrosis - Fibrosis-4 and APRI Index.
Page 4 of 6
SIN No:BI25966393
Patient Name : [Link] DEBNATH Collected : 26/May/2025 09:20AM
Age/Gender : 23 Y 0 M 0 D /M Received : 26/May/2025 09:39AM
UHID/MR No : DAGR.0000182238 Reported : 26/May/2025 11:40AM
Visit ID : DAGROPV194471 Status : Final Report
Ref Doctor : [Link] Client Name : PUP 24X7 HEALTHCARE
IP/OP NO : Center location : DHALESWAR,AGARTALA
DEPARTMENT OF BIOCHEMISTRY
Test Name Result Unit Bio. Ref. Interval Method
RENAL PROFILE/KIDNEY FUNCTION TEST (RFT/KFT) , SERUM
CREATININE 1.10 mg/dL 0.66-1.25 Creatinine
amidohydrolase
.eGFR - ESTIMATED GLOMERULAR 94.12 mL/min/1.73m² >60 CKD-EPI FORMULA
FILTRATION RATE
UREA 44.20 mg/dL 19-43 Urease
BLOOD UREA NITROGEN 20.6 mg/dL 8.0 - 23.0 Calculated
URIC ACID 7.90 mg/dL 3.5-8.5 Uricase
CALCIUM 10.00 mg/dL 8.4 - 10.2 Arsenazo-III
PHOSPHORUS, INORGANIC 4.50 mg/dL 2.5-4.5 PMA Phenol
SODIUM 136 mmol/L 135-145 Direct ISE
POTASSIUM 3.8 mmol/L 3.5-5.1 Direct ISE
CHLORIDE 104 mmol/L 98 - 107 Direct ISE
PROTEIN, TOTAL 8.10 g/dL 6.3-8.2 Biuret
ALBUMIN 4.90 g/dL 3.5 - 5 Bromocresol Green
GLOBULIN 3.20 g/dL 2.0-3.5 Calculated
A/G RATIO 1.53 0.9-2.0 Calculated
Page 5 of 6
SIN No:BI25966393
Patient Name : [Link] DEBNATH Collected : 26/May/2025 09:20AM
Age/Gender : 23 Y 0 M 0 D /M Received : 26/May/2025 09:39AM
UHID/MR No : DAGR.0000182238 Reported : 26/May/2025 11:38AM
Visit ID : DAGROPV194471 Status : Final Report
Ref Doctor : [Link] Client Name : PUP 24X7 HEALTHCARE
IP/OP NO : Center location : DHALESWAR,AGARTALA
DEPARTMENT OF IMMUNOLOGY
Test Name Result Unit Bio. Ref. Interval Method
THYROID PROFILE TOTAL (T3, T4, TSH) , SERUM
TRI-IODOTHYRONINE (T3, TOTAL) 91.53 ng/dL 87-178 CLIA
THYROXINE (T4, TOTAL) 9.67 µg/dL 5.48-14.28 CLIA
TSH (Ultrasensitive/4thGen) 4.400 µIU/mL 0.38-5.33 CLIA
Comment:
For pregnant females Bio Ref Range for TSH in uIU/ml (As per American Thyroid Association)
First trimester 0.1 - 2.5
Second trimester 0.2 – 3.0
Third trimester 0.3 – 3.0
1. TSH is a glycoprotein hormone secreted by the anterior pituitary. TSH activates production of T3 (Triiodothyronine) and its prohormone T4 (Thyroxine). Increased
blood level of T3 and T4 inhibit production of TSH.
2. TSH is elevated in primary hypothyroidism and will be low in primary hyperthyroidism. Elevated or low TSH in the context of normal free thyroxine is often referred
to as sub-clinical hypo- or hyperthyroidism respectively.
3. Both T4 & T3 provides limited clinical information as both are highly bound to proteins in circulation and reflects mostly inactive hormone. Only a very small
fraction of circulating hormone is free and biologically active.
4. Significant variations in TSH can occur with circadian rhythm, hormonal status, stress, sleep deprivation, medication & circulating antibodies.
TSH T3 T4 FT4 Conditions
High Low Low Low Primary Hypothyroidism, Post Thyroidectomy, Chronic Autoimmune Thyroiditis
High N N N Subclinical Hypothyroidism, Autoimmune Thyroiditis, Insufficient Hormone Treatment.
N/Low Low Low Low Secondary and Tertiary Hypothyroidism
Low High High High Primary Hyperthyroidism, Goitre, Thyroiditis, Drug effects, Early Pregnancy
Low N N N Subclinical Hyperthyroidism
Low Low Low Low Central Hypothyroidism, Treatment with Hyperthyroidism
Low N High High Thyroiditis, Interfering Antibodies
N/Low High N N T3 Thyrotoxicosis, Non thyroidal causes
High High High High Pituitary Adenoma; TSHoma/Thyrotropinoma
*** End Of Report ***
Page 6 of 6
SIN No:IM09860875
Patient Name : [Link] DEBNATH Collected : 26/May/2025 09:20AM
Age/Gender : 23 Y 0 M 0 D /M Received : 26/May/2025 09:39AM
UHID/MR No : DAGR.0000182238 Reported : 26/May/2025 11:38AM
Visit ID : DAGROPV194471 Status : Final Report
Ref Doctor : [Link] Client Name : PUP 24X7 HEALTHCARE
IP/OP NO : Center location : DHALESWAR,AGARTALA
TERMS AND CONDITIONS GOVERNING THIS REPORT
1. Reported results are for information and interpretation of the referring doctor or such other medical professionals, who understand
reporting units, reference ranges and limitation of technologies. Laboratories not be responsible for any interpretation whatsoever
2. This is computer generated medical diagnostics report that has been validated by an Authorized Medical Practitioner/Doctor. The
report does not need physical signature.
3. Partial reproduction of this report is not valid and should not be resorted to draw any conclusion.
4. In the case you are not the intended recipient of this report. Please immediately return the same to the concerned issuing desk. Any
disclosure, copy or distribution of any contents of this report, is unlawful and is strictly prohibited.
5. Results delays may occur due to unforeseen circumstances such as non-availability of kits, equipment breakdown, natural calamities,
IT downtime, logistic delays or any other unavoidable event. For certain tests based on analyte stability, criticality of results and in the
interest of patient for having appropriate medical diagnosis, the same test may be outsourced to other accredited laboratory.
6. It is presumed that the tests performed are, on the specimen / sample being to the patient named or identified and the verifications of
particulars have been confirmed by the patient or his / her representative at the point of generation of said specimen
7. The reported results are restricted to the given specimen only. Results may vary from lab to lab and from time to time for the same
parameter for the same patient (within subject biological variation).
8. The patient details along with their results in certain cases like notifiable diseases and as per local regulatory requirements will be
communicated to the assigned regulatory bodies
9. The patient samples can be used as part of internal quality control, test verification, data analysis purposes within the testing scope of
the laboratory.
10. This report is not valid for medico legal purposes. It is performed to facilitate medical diagnosis only
SIN No:IM09860875
